INTRODUCTION
A common attribute of disruption of homeostasis is inflammation. In addition, increasing evidence supports a dynamic role for inflammation either by promoting or by inhibiting different forms of plasticity within the brain (Hocker, Stokes, Powell, & Huxtable, 2017) . Physiological perturbations such as hypoxia promote transcriptional responses that initiate gene-specific regulation to improve cellular oxygenation and decrease ATP expenditure Kiernan, Smith, Mitchell, & Watters, 2016; Oliver et al., 2009; The rostral ventrolateral medulla (RVLM) is composed of a heterogeneous cell population, including the catecholaminergic C1 neurons involved in a range of physiological mechanisms, including adaptive cardiovascular responses to environmental challenges such as hypoxia (Guyenet et al., 2013; Sun & Reis, 1994) . One of the main targets of the C1 cells is the paraventricular nucleus of the hypothalamus (PVH) (Cunningham, Bohn, & Sawchenko, 1990; 
New Findings

• What is the central question of this study?
Microglia are presumed to be the source of inflammatory mediators that contribute to hypoxia-induced neuroinflammation. However, the relationship between microglial activity during hypoxia and inflammatory responses in specific autonomic brain regions is not well understood.
Therefore, we hypothesized that acute hypoxia initiates an immune response in the central nervous system elicited by an increased expression of inflammatory mediators in specific brain areas related to autonomic control.
• What is the main finding and its importance?
Acute hypoxia initiated neuroinflammatory mechanisms specifically in brain autonomic nuclei responsible for cardiorespiratory control, i.e. the rostral ventrolateral medulla and paraventricular nucleus of the hypothalamus.
Our findings emphasize the importance of microglia for the maintenance of autonomic adjustments during physiological challenges, such as hypoxia, or during cardiorespiratory reflex activation elicited by the arterial chemoreceptors. Takakura, & Moreira, 2016) . The PVH is an integrative region in the hypothalamus involved in autonomic and neuroendocrine control and it also plays crucial roles in interactions between the immune and central nervous systems (Coote, 2005; de Wardener, 2001; Ferguson, Latchford, & Samson, 2008; Serrats et al., 2010; Stern et al., 2016) .
Ascending catecholaminergic projections to the hypothalamus from the medulla mediate the stimulatory effects of the cytokine interleukin (IL)-1 on neurosecretory neurons within the PVH, suggesting a vast involvement of this projection system in adaptive responses to immune insults (Schiltz & Sawchenko, 2007) .
Microglia are considered the major contributors to central nervous system (CNS) inflammation. These cells are presumably the source of inflammatory mediators, which contribute to hypoxia-induced neuroinflammation (Smith, Friedle, & Watters, 2013; Wake et al., 2013; Wang, 2007) . However, the relationship between microglial activity during hypoxia and inflammatory responses in specific autonomic brain regions is not well understood. Based on the literature and previous results from our laboratory , the current study examined the hypothesis that acute hypoxia (AH) initiates an immune response in the central nervous system elicited by an increased expression of classic inflammatory mediators (IL-6, IL-1 , tumour necrosis factor (TNF ) and others) in specific brain areas related to autonomic control. To test our hypothesis, the first goal of the current study was to evaluate if AH, a condition observed in many pulmonary diseases in neonates and adults, elicits changes in gene expression of proinflammatory mediators specifically in the RVLM and PVH nuclei, and whether treatment with minocycline, an inhibitor of microglial activity, is able to change the expression of these mediators.
The second goal was to explore if the blockade of microglial activity influences the activity of RVLM and PVH neurons, and thus mediates cardiorespiratory changes during hypoxia.
MATERIAL AND METHODS
Ethical approval
All experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals and approved by the Animal Experimentation Ethics Committee of the ICB/USP (protocol no.
163/2012). The present study followed the ethics policies and regulations required by Experimental Physiology (Grundy, 2015) , and all experimental protocols presented here were carried out in accordance with the standards and the animal ethics principles recognized by the journal and followed a referenced checklist.
Animals
Male Wistar rats (290-310 g at the time of experimentation) were obtained from the Animal Resource Center of the Institute of Biomedical Sciences at the University of São Paulo (ICB/USP).
Acute hypoxia protocol
Hypoxia was performed in conscious, unrestrained adult rats. Prior to the hypoxia protocol, the rats were kept in a Plexiglas chamber (5 litres) flushed continuously with a mixture of 79% nitrogen (N 2 ) and 21% oxygen (O 2 ) at a rate of 1 litre min −1 to acclimatize them to the environment. Before starting hypoxia experiments, rats were first acclimated for 45 min in the chamber and then subjected to acute hypoxia (AH; 8% O 2 , balance N 2 ) or normoxic conditions (control, 21%
O 2 ) for 3 h, as previously demonstrated (Berquin, Bodineau, Gros, & Larnicol, 2000; King, Kline, Ruyle, Heesch, & Hasser, 2013; Silva et al., 2016) . The present protocol was used to investigate Fos-like immunoreactivity, mRNA expression of cytokines and haemodynamic recordings during hypoxia. All experiments were performed at room temperature (24-26 • C).
Minocycline treatment
Minocycline (M9511, Sigma-Aldrich, St Louis, MO, USA) was used to pharmacologically inhibit microglial activity (Miyamoto et al., 2016) .
The treatment was initiated 5 days prior to the experiments at a dose of 30 mg kg −1 day −1 (0.29-0.31 ml), via intraperitoneal injection (I.P.), at the same time every day (Miyamoto et al., 2016) . Fresh aliquots were prepared daily and the pH was adjusted to 7.4. Control rats received I.P. injection of vehicle (saline and distilled water, 0.29-0.31 ml).
RNA extraction and qPCR procedures
Inflammatory mediator levels were quantified in PVH, RVLM and somatosensory cortex regions by real time quantitative polymerase chain reaction (qPCR) after 5 days of vehicle or minocycline treatment under normoxic or hypoxic conditions. For brain tissue collection, animals were anaesthetized with 5% isoflurane in 100% O 2 , killed by decapitation using a guillotine (Harvard Apparatus) and the brains were freshly removed from the skull. The hypothalamic region was dissected approximately at the level of 1.2 mm caudal to bregma, 0.4 mm lateral to the midline and 7.8 mm below the dorsal surface.
At this point, a tissue punch from forelimb somatosensory cortex was collected as a control region for comparison with autonomic areas. RVLM samples were dissected at the level of 2.7 mm caudal to lambda, 8.3 mm below the dorsal surface of the medulla and The amplification reaction was performed on a 7300 Real-Time PCR System (Applied Biosystems). The analysis of qPCR results was performed using the Sequence Detection Software 1.9 (SDS) (Applied Biosystems) calculating threshold (C). The ΔΔC t was calculated and data were expressed as the ratio between the expression of target genes and the housekeeping gene, HPRT. All cDNA samples were assayed in triplicate.
Haemodynamic recordings and spectral analysis
On the fifth day of vehicle or minocycline treatment, the animals were anaesthetized with a mixture of ketamine (100 mg kg −1 ) and xylazine (7 mg kg −1 ; I.P.), and a catheter of polyethylene tubing (PE-10 connected to a PE-50) was inserted into the abdominal aorta through the femoral artery. The muscle and skin layers were separately sutured, and the animals were treated with antibiotic protection (160,000 U kg −1 benzylpenicillin, intramuscular). On the next day, the mean arterial pressure (MAP) and heart rate (HR) were acquired in non-anaesthetized unrestrained rats during normoxia or the AH condition treated with vehicle or minocycline in a time frame of 3 h. Baseline MAP, systolic arterial pressure (SAP) and pulse interval (PI) signals were recorded by connecting the arterial catheter to a pressure transducer (MLT0699, ADInstruments, Bella Vista, NSW, Australia), which was coupled to a preamplifier (FE221 Bridge Amp, ADInstruments), and to a computer data acquisition system (model PowerLab 8SP, ADInstruments). Rats were kept in a Plexiglas recording chamber that was flushed to give normoxia or hypoxia (8% O 2 , balance N 2 ) as described previously.
Spectral analysis of the SAP and PI waveforms was performed using the software CardioSeries (https://www.danielpenteado.com/).
A stable 10 min of SAP and PI records without artefacts or large sudden blood pressure changes of each animal were processed with computer software (LabChart Pro, ADInstruments) that employs an algorithm to detect beat-to-beat inflection points in the pulsatile arterial pressure (PAP) signal. Beat-by-beat series with SAP and PI values were generated and loaded into custom software (CardioSeries V2.4) in order to perform cardiovascular variability within time and frequency domain analysis (Dias et al., 2016) .
SAP and PI power spectral density were estimated by a fast Fourier transform algorithm for time series. Using 10 Hz of interpolation rate, beat-by-beat series were divided into half-overlapping sequential sets with 512 points. The spectra of SAP and PI were integrated into lowfrequency (LF; 0.2-0.75 Hz) and high-frequency (HF; 0.75-3 Hz) bands.
The results were expressed in absolute (ms 2 ) and normalized units (nu), obtained by calculating the percentage of LF and HF power with regard to the total power of the spectrum minus the very low frequency band (<0.2 Hz) (Billman, 2011) . Sympathovagal balance, the LF/HF ratio of PI variability, was also calculated (Akselrod et al., 1981; Dias et al., 2016) .
Chemoreflex analysis
Respiratory rate (f R , breaths min −1 ) and tidal volume (V T , ml kg −1 )
were measured by whole-body plethysmography as described in detail previously (Bartlett & Tenney, 1970; Malan, 1973; Takakura, Barna, Cruz, Colombari, & Moreira, 2014) . All experiments were performed at room temperature (24-26 • C). The rats were placed in a Plexiglas recording chamber (5 litres) that was flushed continuously with a mixture of 79% nitrogen and 21% oxygen (normoxia) at a rate of 1 litre min −1 . During breathing measurements, the flow was interrupted and the chamber was closed for 2 min after each challenge of normoxia or hypoxia. Peripheral chemoreflex activation was induced by hypoxia, i.e. lowering the O 2 concentration in the inspired air to a level of 8% for 10 min. The pressure signal was amplified, filtered, recorded and analysed off-line using PowerLab software (PowerLab 16/30, ML880/P, ADInstruments). Rectal temperature was measured before and at the end of the experiments, and the values were averaged. Changes in the f R , V T and minute ventilation (V E ) (f R × V T ; ml min −1 kg −1 ) were averaged and expressed as means ± SD.
Histology and immunohistochemistry procedures
The rats were deeply anaesthetized with pentobarbital (60 mg kg −1 , I.P., 0.4 ml), then injected with heparin (500 units, intracardially) and finally perfused through the ascending aorta first with 250 ml of phosphate-buffered saline (PBS; pH 7.4) and then with 500 ml of 4% phosphate-buffered paraformaldehyde (0.1 M, pH 7.4). The brains were extracted, cryoprotected by overnight immersion in a 20% sucrose solution in PBS at 4 • C, sectioned in the coronal plane at 40 m on a sliding microtome and stored in cryoprotectant solution (20% glycerol plus 30% ethylene glycol in 50 mM phosphate buffer, pH 7.4) at −20 • C for up to 2 weeks awaiting histological processing. The immunohistochemistry procedures were performed in both groups (vehicle and minocycline) at the same time, using the same reagents, according to previously described protocols .
Using the immunoperoxidase technique, tyrosine hydroxylase (TH) was detected with anti-TH raised in mouse (MAB 318; Millipore, Billerica, MA, USA; dilution 1:1000), and Fos protein was detected using anti-Fos raised in rabbit (Ab-5; Calbiochem, Darmstadt, Germany; dilution 1:5000). Sections were incubated for 24 h at room temperature and diluted in PBS containing 10% normal horse serum (008-000-001; Jackson ImmunoResearch Laboratories, West Grove, PA, USA) and 0.3% Triton X-100. The appropriate affinity biotinylated secondary antibodies used were donkey anti-mouse (715-065-151, Jackson ImmunoResearch Laboratories, dilution 1:500) to TH, and donkey anti-rabbit (711-065-152, Jackson ImmunoResearch Laboratories, dilution 1:500) to Fos, all diluted in PBS containing 1% normal horse serum and 0.3% Triton X-100 incubated for 24 h at room temperature, rinsed again and exposed to Extravidin (E2886; SigmaAldrich; dilution 1:2000) for 4 h at room temperature. Peroxidase reactions were visualized using the glucose oxidase procedure and 3,3 ′ -diamenobenzidine tetrahydrochloride (DAB) as chromogen for TH and associated with 0.5% nickel sulfate for Fos immunostaining.
Sections were rinsed again in PBS, mounted in sequential rostrocaudal order onto gelatin-coated slides, dehydrated through a series of ascending concentrations of ethanol, transferred into xylene, and coverslipped with DPX mountant (06522, Sigma-Aldrich) for histology.
Image acquision and cell counting
A multifunction Zeiss Axioimager A1 microscope (Zeiss, Jena, Munich, Germany) was used to image sections and perform subsequent analysis. Immunoperoxidase-stained sections were examined under bright-field illumination.
The locations of TH and Fos immunoreactivity (TH-ir) in the C1
region were plotted in sections from 11.80 to 12.76 mm caudal to bregma (5 sections per animal); the ventral quadrants were plotted, and profile counts reflect an average of both sides of the medulla. The 
Statistical analysis
A statistical analysis was performed with Prism Version 5.0 (GraphPad Software, Inc., La Jolla, CA, USA). The results are presented as means ± SD. Comparisons between mean values were made using Student's unpaired t test. The comparison between groups (vehicle vs. minocycline) and condition (normoxia vs. hypoxia) at different time points was made by two-way ANOVA. The Bonferroni test was used as the post hoc test. Differences were considered significant at P < 0.05.
RESULTS
Acute hypoxia increases inflammatory mediators in autonomic brain areas
Figure 1a-c shows that AH induces an increase in mRNA levels of IL-6 in the RVLM (2.3 ± 0.9 vs. normoxia: 1.0 ± 0.3; t 21 = 4.59; P = 0.0002; n = 12) and the PVH (1.8 ± 0.7 vs. normoxia: 0.8 ± 0.2; t 10 = 2.69; P = 0.02; n = 7), IL-1 in the RVLM (2.2 ± 1.4 vs. normoxia: 0.8 ± 0.2; t 10 = 2.78; P = 0.01; n = 8) and the PVH (1.7 ± 0.6 vs. normoxia: 0.9 ± 0.4; t 9 = 2.4; P = 0.03; n = 7) and TNF in the RVLM (2.3 ± 1.5 vs. normoxia: 0.7 ± 0.1; t 11 = 2.68; P = 0.02; n = 7). No changes were observed in IL-6, IL-1 or TNF mRNA levels in the cortex in animals exposed to hypoxia (Figure 1a-c) .
In vivo studies have shown that hypoxia may be one of the major stressors for blood-brain barrier (BBB) disruption. Thus, mRNA expression of MMP-9 and MMP-2, which may be involved in the extracellular matrix degradation, were evaluated in the RVLM and PVH of animals exposed to AH (Bauer, Burgers, Rabie, & Marti, 2010) . Figure 1d , e shows that hypoxia elicits an increase in the expression of MMP9 mRNA in the RVLM (2.6 ± 1.0 vs. normoxia: 0.80 ± 0.2; t 12 = 5.2; P = 0.0002; n = 9) and the PVH (1.2 ± 0.7 vs. normoxia: 0.6 ± 0.1; t 15 = 2.63; P = 0.01, n = 9), without changes in MMP2 mRNA level in these nuclei. No changes were observed in CD3 levels in the RVLM and PVH after hypoxia (data not shown).
Minocycline modifies inflammatory profile triggered by AH in the PVH and RVLM
We observed that pretreatment with minocycline (30 mg kg −1 day −1 , 0.29-0.31 ml) decreased the mRNA expression levels of IL-1 (0.94 ± 0.3 vs. vehicle + hypoxia: 2.2 ± 1.4; F 3,20 = 4.7; P = 0.01; n = 8) and TNF (0.7 ± 0.3 vs. vehicle + hypoxia: 2.2 ± 1.5, F 3,21 = 5.2; P = 0.007; n = 7) in the RVLM, without modifying the levels of IL-1 and TNF in the PVH elicited by AH. Interestingly, minocycline evoked a further increase in the mRNA levels of IL-6 in the RVLM (5.1 ± 3.2 vs.
vehicle + hypoxia: 2.4 ± 0.9; F 3,31 = 12.28; P < 0.0001, n = 11), PVH (4.8 ± 0.7 vs. vehicle + hypoxia: 1.8 ± 0.7; F 3,20 = 54; P = 0.04, n = 7) and cortex (4.8 ± 2.1 vs. vehicle + hypoxia: 1.5 ± 0.6; F 3,30 = 21.3; P < 0.001; n = 11) (Figure 1a ).
The levels of MMP9 mRNA were attenuated in the RVLM (0.9 ± 0.4 vs. vehicle + hypoxia: 2.6 ± 1; F 3,21 = 12.84; P = 0.003; n = 9) in rats pretreated with minocycline after AH (Figure 1d ). No differences vehicle + hypoxia: 0.9 ± 0.3; F 3,31 = 0.3; P = 0.5; n = 10) (Figure 1e ).
Minocycline attenuates Fos expression in the RVLM and PVH after AH
Treatment with minocycline decreased the total number of activated neurons in the RVLM/C1 neurons (expressed as Fos + /TH + ; 29 ± 5.1 vs.
vehicle + hypoxia: 60 ± 16; t 4 = 3.14; P = 0.03), without a change in the number of Fos + /TH − neurons (non-C1 neurons) (53 ± 11 vs. vehicle: 64 ± 9.8; t 4 = 1.27; P = 0.2) (Figure 2a 
Minocycline alters autonomic balance in rats exposed to acute hypoxia
No significant changes were observed in MAP of animals treated with vehicle or minocycline during hypoxia challenge (baseline vehicle:
101 ± 5.8 vs. baseline minocycline: 103 ± 6.8 mmHg; 5 min after hypoxia: 110 ± 7.3 vs. minocycline: 116 ± 9.8 mmHg; 30 min after hypoxia: 104 ± 9.3 vs. minocycline: 106 ± 9.7 mmHg; 60 min after hypoxia: 95 ± 7.9 vs. minocycline: 97 ± 7.6 mmHg; 120 min after hypoxia: 95 ± 6.8 vs. minocycline: 94 ± 8.6 mmHg; 180 min after hypoxia:
97± 8.7 mmHg vs. minocycline: 94 ± 10 mmHg; F 1,10 = 5.67; P = 0.58; n = 6), which could be related to unchanged variability of the SAP and the LF component during hypoxia exposure (Figure 3a, c, d ). We noted an increase in HR 60 min after hypoxia in the minocycline-treated group (475 ± 45 vs. vehicle + hypoxia: 407 ± 14 bpm; F 1,10 = 6.43; P = 0.004; n = 6; Figure 3b ). The increase in HR after 60 min of hypoxia was accompanied by an increase in PI variability (25.8 ± 16 vs.
vehicle + hypoxia: 6.3 ± 4.6 ms 2 ; F 1,12 = 2.027; P = 0.0061; n = 7), LF Hypoxia-induced respiratory changes is attenuated by microglial inhibition. Changes in tidal volume (V T , ml kg −1 ; a), respiratory rate (f R , breaths min −1 ; b) and minute ventilation (V E , ml kg −1 min −1 ; c) produced by normoxia or hypoxia exposure (8% O 2 , balance N 2 , 10 min) in rats treated with vehicle or minocycline (30 mg kg −1 day −1 ). *Different from normoxia; †different from vehicle + hypoxia; two-way ANOVA followed by Bonferroni post hoc test; difference was considered significant at P < 0.05; n = 7 (28.5 ± 13.6 vs. vehicle + hypoxia: 14.5 ± 4.5 nu; F 1,12 = 3.16; P = 0.046; n = 7) and LF/HF ratio (0.49 ± 0.2 vs. vehicle + hypoxia: 0.18 ± 0.06 ms 2 ;
F 1,12 = 1.9; P = 0.02; n = 7) (Figure 3f, g, i) .
Effects of minocycline treatment on the hypoxic ventilatory response
As expected, hypoxia increased V T (7.6 ± 0.7 vs. normoxia:
5.5 ± 0.6 ml kg −1 ; P = 0.01), f R (171 ± 9.8 vs. normoxia: 101 ± 7.6 breaths min −1 ; P = 0.04) andV E (1302 ± 188 vs. normoxia:
545 ± 81 ml kg −1 min −1 ; P = 0.03; Figure 4a -c). Figure 4a shows that the treatment with minocycline reduced the hypoxia-induced increase in V T (6.4 ± 0.8 vs. vehicle + hypoxia: 7.6 ± 0.7 ml kg −1 ; F 1,24 = 4.92; P = 0.021; n = 7). Minocycline also attenuated the increase inV E (969 ± 128 vs. vehicle + hypoxia: 1302 ± 188 ml kg −1 min −1 ; F 1,24 = 7.75; P = 0.016; n = 7) produced by hypoxia (Figure 4a, c) .
No detectable changes were observed in the tachypnoeic response to hypoxia in the minocycline group (153 ± 23 vs. vehicle + hypoxia:
171 ± 9.8 breaths min −1 ; F 1,24 = 1.54; P = 0.23; n = 7; Figure 4b ).
Minocycline did not produce significant changes in V T , f R andV E in normoxia (Figure 4a-c) .
DISCUSSION
Our data show that AH initiated neuroinflammatory mechanisms specifically in brain autonomic nuclei responsible for cardiorespiratory control, i.e. the RVLM and PVH. Moreover, minocycline treatment decreased neuronal activation in the RVLM and PVH regions and modulated the cardiorespiratory responses induced by hypoxia.
Acute hypoxia triggers the expression of proinflammatory mediators in the RVLM and PVH
The present study shows that AH induced an increase in the mRNA to the nucleus, where it can induce proinflammatory cytokine release (Cummins, Keogh, Crean, & Taylor, 2016) .
In the present study, we described an upregulation of the expression of mRNA levels of different proinflammatory cytokines in specific autonomic brain regions after AH. This issue was previously addressed during intermittent hypoxia, chronic hypoxia or sustained hypoxia conditions, which elicited an increase in mRNA levels of IL6, IL-1 and TNF in brainstem areas (MacFarlane, Mayer, & Litvin, 2016; Popa, Fu, Go, & Powell, 2011; Smith et al., 2013) . IL-1 and IL-6 mRNA levels were increased 1 day after intermittent hypoxia and remained elevated for 14 days (Smith et al., 2013) . Based on the data described above, our results demonstrate that the cytokines are also increased after 3 h of hypoxia exposure. We acknowledge that our hypoxia protocol is considered severe hypoxia, but this condition is also observed in many pulmonary diseases in neonates and adults.
The role of microglia in hypoxia releasing proinflammatory mediators
Microglia are involved in continuous surveillance of neural properties, playing an active role in neuronal circuit homeostasis (Kettenmann, Hanisch, Noda, & Verkhratsky, 2011; Wake, Moorhouse, Miyamoto, & Nabekura, 2013) . These cells are endowed with numerous receptors capable of detecting physiological disturbances and, based on the activation stimuli, can undergo complex processes such as migrating to the site of injury, proliferating, and secreting interleukins and many other inflammatory mediators (Kettenmann et al., 2011; Pocock & Kettenmann, 2007) . Here, we decided to investigate the role of inhibition of microglial activity in AH-induced mRNA expression of proinflammatory mediators using the only pharmacological tool (minocycline) we presently have to block microglial activation in vivo.
As previously mentioned, AH increased the IL-6 mRNA expression specifically in the RVLM and PVH, but in the group of rats previously submitted to minocycline treatment, we observed a further increase in IL-6 mRNA in both the RVLM and PVH. Previous studies have
shown that IL-6 is widely distributed in the brainstem area, including the RVLM (Takagishi et al., 2010) . Neurons, astrocytes and microglia may be a possible source of IL-6 in the CNS of rats, and interestingly, microglial cells not only secrete IL-6, but also expresses the IL-6R receptor, suggesting a feedback loop mechanism (Jüttler, Tarabin, & Schwaninger, 2002; Peron et al., 2012) . According to our results, microglia presumably exert suppression of IL-6 release by other cells during hypoxia, whereas when inhibited by minocycline, IL-6 mRNA expression increases in a non-specific manner in the brain at low oxygen level.
Astrocytes likely play a dominant role as the source of IL-6 in the CNS (Benveniste, Sparacio, Norris, Grenett, & Fuller, 1990; Gruol & Nelson, 1997) . Considering that within the CNS cellular responses may not occur by themselves, our hypothesis is that during AH we have an interaction between astrocytes and microglia, which may be responsible for the high levels of IL-6. Neurons are also a source of IL-6, and we cannot exclude the involvement of these cells as the source of the high levels of IL-6 mRNA observed after AH (Takagishi et al., 2010) .
Our results showed an increase in IL-1 mRNA levels in RVLM and PVH after AH, which at least in the brainstem could be related to the microglial activity, since the treatment with minocycline reduces IL-1 mRNA in RVLM. We also found that minocycline exerted strong suppression of TNF mRNA expression in the RVLM of rats exposed to AH. The proinflammatory cytokine TNF can be synthesized in the CNS by microglia, astrocytes and certain types of neurons (Kalliolias & Ivashkiv, 2016) . Our data suggest that TNF production during hypoxia can involve microglia activation at the CNS level; however, this hypothesis should be tested more precisely in the future.
Another important fact observed here is that AH increases the expression of MMP9, specifically in RVLM and PVH. MMP9 along with MMP2 is a matrix-degrading enzyme implicated in BBB disruption, and it has been intensively studied during neuroinflammatory responses (Cunningham, Wetzel, & Rosenberg, 2005; Yang, Estrada, Thompson, Liu, & Rosenberg, 2007) . In accordance with our data, it has been shown that brain lysates of mice exposed to hypoxia (8% O 2 for 48 h) have a significant increase in neurovascular permeability associated with increased MMP9 activity specifically in vascular structures (Bauer et al., 2010) . No differences in MMP2 expression were detected in hypoxic brains, suggesting that MMP9 is activated rather than MMP2 during AH. The treatment with minocycline was effective to attenuate the MMP9 mRNA expression in both RVLM and PVH under AH, suggesting that microglia can play some role mediating MMP9 expression (Konnecke & Bechmann, 2013) . Some studies show that IL-1 and TNF are potent stimulators of MMP9 expression in cultured astrocytes and microglia. Interestingly, we also noticed an increase of both interleukins under AH, and an attenuation after minocycline treatment Gottschall, Yu, & Bing, 1995) .
Minocycline attenuates Fos protein expression in RVLM and PVH after hypoxia
We and others have already shown that AH increases Fos expression in the RVLM and PVH neurons of rats (Berquin et al., 2000; King et al., 2013; Silva et al., 2016; Smith, Buller, & Day, 1995) . Additionally, selective depletion of PVH-projecting C1 neurons attenuates Fosactivated neurons in the PVH after AH . Here, we demonstrated that minocycline treatment significantly reduced the number of Fos-activated neurons in the AH protocol, further supporting the influence of microglia on neuronal activity in the respiratory adjustments at low oxygen condition.
Characteristics of the neural components of the chemoreflex pathway related to inflammatory mechanisms triggered by hypoxia are still not fully understood, and it is crucial to elucidate neuroimmune mechanisms which may be involved in these responses. As previously mentioned, the increase in mRNA expression of inflammatory mediators was specifically localized in the RVLM and PVH, both regions involved in the chemoreflex pathway and autonomic control (Coote, 2005; Cruz, Bonagamba, Machado, Biancardi, & Stern, 2008; King et al., 2013; Reddy et al., 2005; Silva et al., 2016) . The RVLM could be an integration site and play a role in sensing hypoxia and transmitting immune signals, engaging PVH, and possibly the HPA axis.
In accordance with this hypothesis, Buller and colleagues suggested that reciprocal connections between the brainstem and the hypothalamus can be involved in inflammatory challenges, since RVLM Fos-expressing cells after systemic administration of IL-1 project to parvicellular PVH divisions (Buller, Dayas, & Day, 2003; Buller, Xu, Dayas, & Day, 2001) . Moreover, ascending catecholaminergic projections to the PVH appear to be essential in mediating stimulatory effects of IL-1 on PVH neurosecretory neurons (Schiltz & Sawchenko, 2007) .
We also found that minocycline did not reduce the number of hypoxia-activated neurons in two key areas related to cardiorespiratory control, the commissural aspect of the nucleus of the solitary tract (cNTS) and the SON. Peripheral chemoreceptors, located mainly in the carotid body in the rat, detect changes in the arterial blood gases and send signals to the cNTS (Guyenet, 2014) . The SON is involved in neuroendocrine responses to chemoreceptor stimulation and showed Fos expression after hypoxia exposure in conscious rats (Berquin et al., 2000) . Similar to the PVH, the SON receives catecholaminergic inputs from the ventrolateral medulla, and in addition to hypoxia, systemic IL-1 injection also elicits an increase in Fos immunoreactivity (Buller et al., 2001; Sawchenko & Swanson, 1982 
Minocycline alters autonomic balance and the ventilatory reflex during AH
Animals treated with minocycline exhibit a significant increase in HR when compared with vehicle. PI variability was increased in the minocycline group, accompanied by an increase in the LF component of PI and the LF/HF ratio. These data suggest that under hypoxic conditions, where the sympatho-vagal balance is essential for cardiac functions, inhibition of microglial activity disrupted the organization of the autonomic responses. The ability of minocycline to change autonomic balance was previously shown in spontaneously hypertensive rats, and the possible mechanisms have been related to minocycline's capacity to cross the BBB and act as an inhibitor of microglial activation (Santisteban et al., 2015) .
Acute hypoxia elicits a specific pattern of activation of the sympathetic outflow, but the exact molecular interactions between microglia and the autonomic nervous system during the activation of peripheral chemoreceptors remains unclear. Our findings indicate that inhibition of microglia exacerbates the cardiac sympathetic output after 60 min of hypoxia, supporting the concept that microglia cells contribute to the regulation of the autonomic nervous system during physiological challenges.
Minocycline also attenuated the hypoxia ventilatory response.
Our findings are in agreement with the literature, indicating that microglia inhibition affects breathing activity, since intracisternal injection of minocycline reduces the hypoxia ventilatory response (Lorea-Hernandez, Morales, Rivera-Angulo, Alcantara-Gonzalez, & Pena-Ortega, 2015). In addition, minocycline was also able to decrease the ventilatory acclimatization of 24 h under hypoxia, due to blockade of the continuous increase in tidal volume (Tadmouri, Champagnat, & Morin-Surun, 2014) . The exact mechanisms involved in the modulation of respiratory brain areas by microglia it is not clear, but probably involve inflammatory mediators and neurotransmitters in the ventral respiratory column. Prostaglandin E2 (PGE2), the major reaction product of cyclooxygenase 2 (COX-2), differentially stimulates respiratory activities generated within the preBötzinger complex, besides modulating sigh, gasping and eupnoeic activity (Koch et al., 2015) . Hypoxia can increase COX-2 expression and subsequently increase protein levels of PGE2 (Perez-Polo, Reilly, & Rea, 2011) . In the CNS, microglia are the source of prostaglandin production in postnatal rats after hypoxia (Li et al., 2009) , and this may be the link between microglia and the modulation of respiratory responses.
Taken together, our findings indicate that AH leads to an increase in proinflammatory mediators with influence on the cardiorespiratory network. The data also emphasize the importance of microglia for the maintenance of autonomic adjustments during physiological challenges, such as hypoxia, or during cardiorespiratory reflex activation elicited by peripheral chemoreceptors.
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